Study Illuminates Link Between Hematuria Remission and Outcomes for Immunoglobulin A Nephropathy Patients
source: pixabay.com

Study Illuminates Link Between Hematuria Remission and Outcomes for Immunoglobulin A Nephropathy Patients

Immunoglobulin A nephropathy (IgAN) is a glomerular disease which can lead to kidney failure. Between 70 and 100 percent of all IgAN patients also are diagnosed with microscopic hematuria, but…

Continue Reading Study Illuminates Link Between Hematuria Remission and Outcomes for Immunoglobulin A Nephropathy Patients
Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis
source: pixabay.com

Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis

According to a story from BioSpace, a recent study conducted by the biotechnology company Goldfinch Bio in collaboration with academic partners is highlighting the importance of proteinuria in determining outcomes…

Continue Reading Collaborative Study Highlights the Importance of Proteinuria in Focal Segmental Glomerulosclerosis
Pegcetacoplan Registrational Programs Begun for C3G, ALS, and IC-MPGN
Photo by Robina Weermeijer on Unsplash

Pegcetacoplan Registrational Programs Begun for C3G, ALS, and IC-MPGN

  According to a press release, biopharmaceutical company Apellis Pharmaceuticals ("Apellis") recently launched registration programs to explore pegcetacoplan for patients with C3 glomerulopathy (C3G), amyotrophic lateral sclerosis (ALS), and immune…

Continue Reading Pegcetacoplan Registrational Programs Begun for C3G, ALS, and IC-MPGN
This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
source: pixabay.com

This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients

Lupus nephritis causes kidney inflammation and can often lead to chronic kidney disease (CKD). An issue that medical professionals have faced is predicting the likelihood of individual patients developing CKD.…

Continue Reading This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available
source: pixabay.com

Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available

According to a story from Physician's Weekly, while measuring the concentration of albumin (albuminuria) is widely considered the standard method for staging and screening for chronic kidney disease, a different…

Continue Reading Alternate Method for Staging Chronic Kidney Disease Could be Cheaper and More Widely Available

Dosing Begins in Phase 3 IgA Nephropathy Clinical Trial

According to a story from BioSpace, the biopharmaceutical company Retrophin, Inc., recently announced that the first patient has been treated in the company's Phase 3 clinical trial testing sparsentan as…

Continue Reading Dosing Begins in Phase 3 IgA Nephropathy Clinical Trial
Clinical Trials Underway for Potential Lupus Nephritis and FSGS Treatment
Source: Pixabay

Clinical Trials Underway for Potential Lupus Nephritis and FSGS Treatment

According to Business Wire, a pharmaceutical company, Aurinia Pharmaceuticals Inc., recently announced that they have enrolled the first lupus nephritis patients in the AURORA 2 extension study. Not only this, but Aurinia…

Continue Reading Clinical Trials Underway for Potential Lupus Nephritis and FSGS Treatment
Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results
Source: Pixabay

Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results

The phase 3 trial of the drug Inlyta for the treatment of patients with a high risk of recurrent renal cell carcinoma (kidney cancer) following nephrectomy (removal of a kidney)…

Continue Reading Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results
Researchers Discover Causes of Graft-Verus-Host-Disease
Source: Pixabay

Researchers Discover Causes of Graft-Verus-Host-Disease

Research into graft-versus-host-disease (GVHD), a condition that can occur after bone marrow transplants, has yielded promising results. A study, reported by BrightSurf, found that a particular group of microRNA molecules involved…

Continue Reading Researchers Discover Causes of Graft-Verus-Host-Disease